Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2004
Reporting Period: First Quarter of 2004
This filing serves as a notification of the company's financial results for the first quarter of 2004. The detailed financial data is not contained within the body of this 8-K but is incorporated by reference via a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are disclosed in the attached exhibits (99.1 and 99.2) which are referenced but not included in the provided text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release for year-over-year comparisons.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. Such information is expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2004 revenue and earnings per share figures.
- Examine Exhibit 99.2 for supplemental data not included in the main press release.
- Verify year-over-year growth rates and margin trends in the referenced exhibits.
- Check the press release for any updated full-year guidance or forward-looking statements.